Global Biobanking Market, By Product and Services (Equipment, Consumables, Service, Software), Sample Type (Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products), Storage Type (Manual Storage, Automated Storage), Type of Biobank (Population based Biobanks, Disease- Oriented Biobanks), Ownership (National/Regional Agencies, Nonprofit Organization, University, Private), Application (Regenerative Medicine, Life Science Research, Clinical Research), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Biobanking Market
The biobanking market is expected to witness market growth at a rate of 6.10% in the forecast period of 2022 to 2029. Data Bridge Market Research report on biobanking market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The expansion of biotechnology sector globally is escalating the growth of biobanking market.
Biobanking refers to a technique of collecting and preserving biological materials that can be further utilized for diagnosis, biodiversity research and studies. Biobanks play an important role in developing personalized medicine, maintaining and updating age demographic databases, and supporting biomedical research studies.
The increase in genomic research activities for studying diseases across the globe acts as one of the major factors driving the growth of biobanking market. The rise in trend of conserving cord blood stem cells of newborns for various health advantages, and government and private funding to support regenerative medicine research accelerate the market growth. The increase in the global burden of major diseases, and rise in need for cost-effective drug discovery and development further influence the market. Additionally, expansion of biotechnology sector, advancements in the healthcare sector, rise in population, surge in healthcare expenditure and advances in biobanking positively affects the biobanking market. Furthermore, rise in focus on the research and development of cell therapies extend profitable opportunity to the market players in the forecast period of 2022 to 2029.
On the other hand, high cost associated with the automation and issues related to biospecimen sample procurement are expected to obstruct the market growth. Long-term sustainability of biobanks are projected to challenge the biobanking market in the forecast period of 2022-2029.
This biobanking market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on biobanking market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Biobanking Market Scope and Market Size
The biobanking market is segmented on the basis of product and services, sample type, storage type, type of biobank, ownership and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product and services, the biobanking market is segmented into equipment, consumables, service and software. The equipment segment is further segmented into storage equipment, sample analysis equipment, sample processing equipment and sample transport equipment. The consumables segment is further segmented into storage consumables, analysis consumables, processing consumables, and collection consumables. Service segment of the biobanking market is further segmented into storage service, processing services, transport services, and supply services.
- On the basis of sample type, the biobanking market is segmented into blood products, human tissue, cell lines, nucleic acids, biological fluids and human waste products.
- On the basis of storage type, the biobanking market is segmented into manual storage and automated storage.
- On the basis of type of biobank, the biobanking market is segmented into population based biobanks and disease- oriented biobanks.
- On the basis of ownership, the biobanking market is segmented into national/regional agencies, nonprofit organization, university and private.
- On the basis of application, the biobanking market is segmented into regenerative medicine, life science research and clinical research.
Biobanking Market Country Level Analysis
The biobanking market is analysed and market size insights and trends are provided by country, product and services, sample type, storage type, type of biobank, ownership and application as referenced above.
The countries covered in the biobanking market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the biobanking market because of the continuous investment in the collection, establishment, and processing of large-scale datasets within the regions. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in the government initiatives in the region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The biobanking market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biobanking market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biobanking market. The data is available for historic period 2010-2020.
Competitive Landscape and Biobanking Market Share Analysis
The biobanking market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to biobanking market.
Some of the major players operating in the biobanking market report are Thermo Fisher Scientific Inc, Tecan Trading AG, QIAGEN, Hamilton Company., Brooks Life Sciences, TTP Labtech, VWR International, LLC, Promega Corporation, Worthington Industries, BD, Merck KGaA, Biokryo GmbH, Cell&Co BioServices, RUCDR Infinite Biologics, Modul-Bio, STEMCELL Technologies Inc, BioLifeSolutions Inc., BioCision., and Taylor-Wharton., among others.
SKU-